{"summary": "autophagy is a conserved catabolic process that is involved in cellular homeostasis. it can be a selective or non-selective lysosomal degradative process. it is activated by stresses such as starvation or rapamycin via regulatory signaling complexes. autophagy acts as a cleaning mechanism by removing or degrading unnecessary materials from the body. autophagy defects can affect the pathogenesis of many diseases. autophagy plays important roles in cancer metastasis; 4-acetyl-antroquinonol B has been shown to modulate autophagy and prevent the growth of ovarian cancer cells. autophagy is also important in neuronal homeostasis, with its dysfunction associated with numerous neurodegenerative disorders. mutations in autophagy regulation genes have been shown to induce neurodegenerative diseases such as amyotrophic lateral sclerosis, Alzheimer\u2019s disease, and familial Parkinson\u2019s disease. mutations in autophagy regulation genes have been shown to induce neurodegenerative diseases. autophagy can kill or eradicate infectious disease-causing pathogens via the autophagosome or autophagolysosome (autolysosome) to prevent infection-causing pathogens. autophagy can kill or eradicate infectious disease-causing pathogens via the autophagosome. autophagy is the first mechanism to clear endogenous debris and exogenous substances. autophagy also regulates the development [67], differentiation [5], and maturation [68] of cells. autophagy is also involved in clearing abnormal protein accumulations and correcting mitochondrial disorganization. autophagy and apoptosis are interwoven and have been implicated in both microbial infections and cancers [26,76] autophagy might play both physiological and pathological roles since it is involved in overcoming cell stresses [19,77,78]. autophagy is an essential, evolutionarily conserved, catabolic, and self-degradative process that mediates the destruction of cytoplasmic macromolecules. autophagy can prevent or treat cancer by killing cancerous cells and degrading endogenous or exogenous carcinogens. autophagy may have dual roles in cancer as it is involved in stem cell-related resistance to anti-cancer therapy (radioresistance and chemoresistance), metastasis, and tumor recurrence. tive autophagy has not been well studied, whereas the latter has been studied extensively. autophagy is known to stimulate neurite remodeling in developing brains. many factors have been evaluated as induced autophagy stimuli. complexes to initiate autophagy, the ULK1 (unc51-like autophagy activating kinase 1) protein kinase complex and the PI3KC3-C1 (class III phosphatidylinositol 3-kinase complex I) lipid kinase complex have also been shown to be involved in this process. upstream signaling pathways common to both autophagy and apoptosis are known to be induced autophagy is fine-tuned by epigenetic regulation, through histone arginine methyltransferase, CARM1, a novel enzyme that follows histone H3R17 dimethylation. vitamin D receptor modulates autophagy in normal mammary glands and luminal breast cancer cells, suggesting a potential therapeutic link between vitamin D levels and breast cancer risk. initiation factor 2 (eIF2) kinase pathway consists of a family of evolutionarily conserved serine/threonine kinases that regulate stress-induced translational arrest. the autophagosome fuses with the lysosome or late endosomal multivesicular bodies (MVBs) to degrade the materials within it. a high degree of curvature in the initiating membranes is a prominent feature of CVT vesicles during mammalian autophagy [132]. microautophagy occurs during the biogenesis of multi-vesicular bodies (MVBs), which deliver soluble proteins to the late endosomes. only proteins with a C-terminal pentapeptide KFERQ motif undergo CMA; the HSC70 cochaperone identifies cytosolic proteins the substrate protein (chaperon-mediated) is then translocated into the lysosome by LAMP-2A. the substrate is then unfolded and translocated through LAMP-2A-enriched. the substrate is then unfolded and translocated through the substrate. autophagy is an evolutionarily conserved process induced via multiple signaling pathways by numerous stimuli. stress and nutrient starvation inhibit mTOR to initiate autophagy via at least four molecular complexes. PI3K complexes include the unc-51-like kinase (ULK) complex. atg4, Atg7, and Atg3 process LC3 into LC3-II, a molecular marker for autophagosomes [86] following autophagosomal closure, the Atg5-Atg12-Atg16 complex dissociates from the autophagosome. atg9 is required for the formation of intraluminal vesicles and is localized within the autolysosome. HS1BP3 is thought to reduce phospholipase D1 (PLD1) activity. it is thought to reduce phospholipase D1 (PLD1) activity and localization to ATG16L1 and transferrin receptor (TFRC)-positive vesicles. it regulates levels of PA and the lipid content of autophagosome precursor membranes. genome-wide studies in C. elegans identified 139 genes that promote autophagy when inactivated. long ncRNAs (lncRNAs) often possess regulatory functions. RNA-binding proteins (RBPs) are post-transcriptional and co-translational regulators with RNA-related functions. atg5-Atg12-Atg16 complex is recruited to prevent premature fusion of vesicle to the lysosome. atg9 further elongates the membrane and forms intraluminal vesicles. autosis involves enhanced cell-substrate adhesion, focal ballooning of perinuclear space, dilation and fragmentation of the endoplasmic reticulum. autosis can be partially rescued by knocking down Atg13 or Atg14 or using 3-methyladenine. autosis is selectively blocked when the Na+/K+-ATPase pump is inhibited. autosis has been observed in patients with severe liver anorexia nervosa. beclin 1-mediated autophagy is inhibited by ER-localized Bcl-2. transgenic expression of Bcl-2 was shown to inhibit autophagy in mouse heart muscles. BH3 domain has a critical role in the interaction between these proteins. autophagy inhibits apoptosis and accelerated mortality in sepsis models. TRAIL combined with a novel chalcone derivative, Chal-24, was found to remarkably increase lung cancer cell cytotoxicity via autophagy-mediated apoptosis. sirtuins are NAD+-dependent protein deacetylases involved in autophagy and necroptosis, as well as transcription, stress resistance, and aging. the binding of SIRT-2 to receptor-interacting protein (RIP) 3 mediates RIP1 deacetylation in response to TNF; RIP1 and RIP3 then form a complex, which triggers necroptosis [197] autophagy and Necrosis refers to increase in cell volume caused by organelle swelling. cell is unable to undergo apoptosis and undergoes necrosis instead. ATP depletion also activates AMP-activated kinases (AMPK) [204]. autophagy is fine-tuned by epigenetic regulation, through histone arginine methyltransferase. vitamin D receptor modulates autophagy in normal mammary glands and luminal breast cancer cells. autophagy can be divided into macroautophagy, microautophagy, and CMA. autophagy is a novel evolutionarily conserved function of the eukaryotic initiation factor 2 (eIF2) kinase pathway. it consists of a family of evolutionarily conserved serine/threonine kinases that regulate stress-induced translational arrest. the autophagosome is initiated when a portion of cytoplasm containing a cellular organelle is sequestered to form the autophagosome. cytoplasm-to-vacuole targeting (CVT) pathway is used to transport vacuolar hydrolases into the vacuole of budding yeast cells. microautophagy occurs during the biogenesis of multi-vesicular bodies (MVBs), which deliver soluble proteins to the late endosomes. lysosomal proteases degrade the contents of these vesicles. apeptide KFERQ motif undergoes CMA; the HSC70 cochaperone identifies cytosolic proteins containing this sequence and delivers them to the lysosome. cytosolic chaperone protein HSPA8/HSC70 is present in a complex with other chaperone proteins. a portion of cytoplasm containing a cellular organelle is sequestered to form the autophagosome. the autophagosome fuses with the lysosome or late endosomal multivesicular bodies to degrade the materials within it. the mitochondrial outer membrane protein, Atg32, is a receptor for selective autophagy. a high degree of curvature in the initiating membranes is a prominent feature of CVT vesicles during mammalian autophagy [132]. microautophagy occurs during the biogenesis of multi-vesicular bodies (MVBs), which deliver soluble proteins to the late endosomes. only proteins with a C-terminal pentapeptide KFERQ motif undergo CMA. cytosolic proteins containing this sequence are transported to the lysosome. the substrate protein (chaperon-mediated) is then translocated into the lysosome by LAMP-2A for degradation. the levels of LAMP-2A tightly regulate the rate of CMA at the lysosomal membrane. autophagy is an evolutionarily conserved process induced via multiple signaling pathways by numerous stimuli including nutrient starvation [16,105], hypoxia [82,146], oxidative stress [109,147], pathogen infection [39,148], and ER stress [149]. stress and nutrient starvation inhibit mTOR to initiate autophagy via at least four molecular complexes. atg5-Atg12-Atg16 complex is recruited to the pre-autophagosomal structure (PAS) where it associates with the outer membrane of the phagophore. the second ubiquitin-like system stimulates the binding of phosphatidylethanolamine (PE) and Atg8/microtubule-associated protein 1 light chain 3 (LC3). LC3 has a high affinity for the lysosome when bound to the autolysosomes are directly related to cell trafficking pathways. HS1BP3 is thought to reduce phospholipase D1 (PLD1) activity. it regulates the levels of PA and the lipid content of autophagosome precursor membranes. TRIM and CULLIN have been recognized as important autophagy regulators. genome-wide studies in C. elegans identified 139 genes that promote autophagy when inactivated. long ncRNAs (lncRNAs), which are longer than 200 nucleotides, often possess regulatory functions. miR188-3 has been found to regulate Atg7 expression. AMBRA1 activates PI3K complex encompassing Atg15, vacuolar protein sorting 15 (VPS15), VPS34, Beclin-1 and AMBRA1. atg5-Atg12-Atg16 complex is recruited to prevent premature fusion of vesicle to the lysosome. LC3-II is present on both the inner and outer surfaces of the autophagosome. autosis can be partially rescued by knocking down Atg13 or Atg14. autosis is selectively blocked when the Na+/K+-ATPase pump is inhibited. autosis has also been observed in patients with severe liver anorexia nervosa. beclin 1-mediated autophagy is inhibited by ER-localized Bcl-2 [179] beclin 1 mutants induce higher levels of autophagy than wild-type counterparts. non-conjugated Atg12 can bind and inhibit Mcl-1 and Bcl-2. TRAIL can also protect cells against apoptosis induced by tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) by altering the concentrations of Bcl family members. TRAIL combined with a novel chalcone derivative, Chal-24, was found to remarkably increase lung cancer cell cytotoxicity via autophagy-mediated apoptosis. inhibiting the mTOR signaling pathway can prevent apoptosis and even enhance necroptosis. starvation protects cells from zVAD-mediated necroptotic death. autophagy and Necrosis Necrosis refers to increase in cell volume caused by organelle swelling, which results in plasma membrane rupture and the loss of intracellular contents. when ATP is depleted, the cell is unable to undergo apoptosis and undergoes necrosis instead. beclin 1-mediated autophagy is inhibited by ER-localized Bcl-2. transgenic expression of Bcl-2 was shown to inhibit autophagy in mouse heart muscles. beclin 1 mutants induce higher levels of autophagy than wild-type counterparts. autophagy inhibits apoptosis and accelerated mortality in sepsis models. TRAIL combined with a novel chalcone derivative, Chal-24, was found to remarkably increase lung cancer cell cytotoxicity via autophagy-mediated apoptosis. sirtuins (SIRT) are NAD+-dependent protein deacetylases. they are active in both autophagy and necroptosis, as well as transcription, stress resistance, and aging. the binding of SIRT-2 to receptor-interacting protein (RIP) 3 mediates RIP1 deacetylation. is Necrosis refers to the increase in cell volume caused by organelle swelling. the cell is unable to undergo apoptosis and undergoes necrosis instead. the fate of the cell depends on the balance between autophagy and necrosis. Bcl-xL regulates xenophagy, and Bcl-xL knockout cells are more susceptible to Streptococcus pyogenes infection. bacterial peptidoglycans are detected by nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) which trigger a pro-inflammatory immune response. oligomerization domain (NOD)-like receptors (SLRs) recruits autophagy proteins including unc-51-like kinase (ULK) 1/2 with lipid kinase complexed with Beclin 1 and Atg16L1. mutant C. elegans with defective autophagy genes exhibit increased susceptibility to bacterial infection. infection with group A Streptococcus species induces anti-apoptotic Bcl-xL expression which inhibits autophagy directly by suppressing autophagosome-lysosome fusion. Icobacterium tuberculosis is known to induce miR144 expression in human macrophages and monocytes. many bacteria have evolved mechanisms to overcome autophagy. these bacteria may express receptors to prevent or enhance phagosome formation. some bacteria hijack autophagosomes and use by-products of autophagic degradation. autophagy targets invading intracellular bacterial pathogens for degradation. autophagy is differentially regulated in tuberculoid and lepromatous leprosy. autophagy controls Mycobacterium leprae; in lepromatous cells, blocking of Bcl-2-mediated autophagy promotes bacterial persistence. leprae-mediated inhibition of autophagy in lepromatous macrophages as autophagy levels were restored in lepromatous patients. autophagy helps to clear viral pathogens during infection via various molecular mechanisms, regulates immune responses, and prevents harmful overactivation and inflammation. autophagy is stimulated by the salicylamide derivatives against cytopathic bovine viral diarrhea virus (cp-BVDV) infection suppresses autophagy and NF-B anti-viral activities by degrading Atg5-Atg12 using the viral protein 3Cpro. however, autophagy is often hijacked by viral pathogens and can be modulated to their own benefit. autophagy-deficient cells are more susceptible to apoptosis upon influenza infection [253,254], while using pharmacological reagents or RNA interference to alter cellular autophagy can impair viral protein accumulation [255]. paramyxoviruses such as Newcastle disease virus (NDV) have been shown to trigger autophagy in U251 glioma cells to enhance viral replication. virus 68 encode proteins that bind Beclin 1 to prevent autophagy initiation. inhibiting host autophagy could cause cervical cancer via hrHPV. autophagy also plays a critical role in the replication of coronaviruses. autophagy inhibitors are better candidate targets than conventional anti-viral therapies using interferons. upregulating cellular autophagy was reported to inhibit IFN-/Ribavirin (RBV)-based anti-viral therapy. adenoviral infection may be favored by autophagy via an increase in ATP. autophagy inhibition has been reported as a new molecular mechanism by which HSV-1 escapes innate immunity, resulting in fatal disease. autophagic cell death of alveolar epithelial cells has been observed to play a major role in the high mortality rate caused by H5N1 influenza virus infection. autophagy-blocking agents could have preventative and therapeutic effects against this virus. p62 (a signaling adaptor/scaffold protein) is involved in the formation of intracellular ubiquitin-related protein aggregates. atg7-deficient mice exhibit enhanced accumulation of p62 and ubiquitinated protein aggregates. autophagy has also been implicated in benign hepatomas. ribosomal S6 kinases (S6Ks) 1 and 2 promote cell cycle progression. novel anti-cancer molecule, HA15, induces ER stress and increase protein response. autophagy suppresses tumor formation by preventing inflammation, accumulation of proteins and organelles damaged by necrosis. er of trichosanthes kirilowii exhibited anti-cancer properties against different human ovarian cancer cells via a pathway common to both autophagy and apoptosis. autophagy induction promotes the survival of normal cells and may also promote tumor cell survival. hypoxia, metabolic stress, energy shortage, oxidative stress-damaged mitochondria, and organelles can be caused by cancer-causing genes or cancer treatments. autophagy is expected to cause ubiquitinated proteins to accumulate and p62 levels to increase. in hepatic tumors, autophagy suppresses spontaneous tumorigenesis via cell-intrinsic pathways while p62 accumulation promotes tumor formation. autophagy inhibits autophagy in response to starvation or stress. autophagy is vital for neuronal homeostasis, and its deregulation is highly associated with numerous neurodegenerative effects. autophagy is vital for neuronal homeostasis [326], and its deregulation is highly associated with numerous neurodegenerative effects. autophagosomal accumulation and anomalies in the endosomal-lysosomal pathway have been observed in post-mortem human brain tissues via electron microscopy. autophagy deficiency resulted in neuronal loss in the cerebral and cerebellar cortices in a mouse model [334] expression is lower in the brains of patients with Alzheimer\u2019s disease. apoptosis-stimulating protein p53-2 (ASPP2/53BP2L) has different effects on autophagy in neurons stimulated with different levels of gp120. regulating autophagy in the CNS could be a therapeutic approach against HIV-associated neurocognitive disorders. autophagy is involved in innate immune cell differentiation, degranulation, phagocytosis and extracellular trap formation involving neutrophils, eosinophils, mast cells, and natural killer cells. autophagy also regulates the functional responses of immune cells, such as phagocytosis, antigen presentation, cytokine production, control of inflammasome activation, tolerance, and their consequences. anti-inflammatory cytokine, IL-10, inhibits autophagy by activating mTOR complex 1 [357] and inhibits starvation- and IFN-induced autophagy via Bcl-2 and Beclin 1 in various autoimmune and inflammatory disorders. autophagy has predisposing, pathogenic, and therapeutic roles in autoimmunity. autophagy defects have been observed in T cells, B cells, and macrophages. lysosomal proteins have a central role in antigen processing. increased lysosomal pH may be important lysosomal malfunction involved in autoimmunity. patients with congestive heart failure, coronary artery disease, hypertension, and aortic valvular disease display increased autophagosomal accumulation in their myocardial biopsies. autophagy levels vary in normal and affected hearts, with constitutive autophagy maintaining normal structure and function. contractile dysfunction and hypertrophy have been observed during cardiomyopathy [370], while cell culture studies have revealed that autophagic gene deficiency can cause the accumulation of unwanted proteins. iron levels are tightly regulated in cells; nutrient deficiency induces autophagy. degradation of these contents provides essential resources that either promote cell survival or lead to cell death. iron plays a major role in mitochondrial ATP metabolism and other cellular processes. a free intracellular Fe antagonist that prevents cell death via exogenous ROS. ferritin is degraded to release the stored iron to maintain iron homeostasis. autophagy in Obesity and diabetes autophagy is involved in obesity. in obese animals, hepatic autophagy signaling is impaired by NO-induced hepatic autophagy repression, which ultimately causes the progression of type 2 diabetes. the potential role of autophagy in ameliorating/deteriorating diseases and homeostasis have been enumerated in Table 2. antiviral activity Rapamycin, chloroquine and small interfering RNAs target Atg5 and Beclin 1- virus production is hampered in new Castle disease virus (NCDV) sun et al., 2014 [259] inhibition of maturation of autophagosome- HIV NS4A-induced autophagy induces virus replication. phosphatidylinositol 3 kinase/Akt/mTOR pathway and inhibition of autophagy- induce cellular entry of \u2013Human Papilloma virus (HPV) type 16. human nuclear ribonucleoprotein K (hnRNP-K) and ubiquilin 4 (UBQLN4) help in viral replication. paramyxovirus V proteins Mandhana et al., 2018 [41] Altering nonstructural proteins of west Nile virus affects LC3 modification and aggregation Martn-Acebes et al., 2015 [43] 2 Bacterial infection Anti-bacterial activity In Bcl-xL knockout cells, Streptococcus pyogenes infection is promoted Nakajima et al. inactivation of Beclin 1 and Atg5 affects autophagy Levine, 2007 [289]; Yue et al., 2009 [293] UV radiation resistance associated gene (UVRAG) can suppress tumorigenicity and proliferation of colon cancer. autophagy inhibition leads to cell death in tumors acting like an RAS-activated tumor Guo et al., 2011 [312] In hepatocellular carcinomas, increased autophagy may cause cancer cells to go into dormancy. anomalies in endosomal-lysosomal pathway and accumulation of autophagosomes lead to Alzheimer\u2019s, Parkinson\u2019s and Huntington\u2019s diseases. anomalies in endosomal-lysosomal pathway and accumulation of autophagosomes- lead to Alzheimer\u2019s, Parkinson\u2019s and Huntington\u2019s diseases. inflammatory bowel disease Anti-effect Reduction in TNF-induced apoptosis in gut epithelium Pott and Maloy, 2018 [400] Pro-effect Goblet cell function, cytokine production or NOD2, ATG16L1, and IRGM gene regulation affect pathogenesis of inflammatory bowel disease Iida et al., 2017 [401] 7 Lifestyle diseases Obesity Causes biochemical disturbance, ER stress, mitochondrial dysfunction induces cytotoxic bixanthone from Garcinia griffithii and G. pavifolia selectively kill cervical cancer cells via inducing autophagy XU H, Zhang H, Lao Y, Wang X, Yang D, Yang D, Yang D, Chen S, Lin C, Bian Z, Lu A, Chan ASC, 17.05.16 Grant Xu et al., 2016 [404] Substituted thioxanthenone autophagy inhibitor highly potent peptides to control cancer and neurodegenerative diseases WO 2010011952 Inhibition of autophagy by administering a FLIP protein interfering with the formation of the LC3-Atg4-Atg7-Atg3 conjugation complex. ubiquitin-like conjugation systems atg5-Atgl2, LC3, fusion complex, SNARE protein and transcription factor EB Zaupa C, Hortelano J, Silvestre N, Spindler A 25.08.16 Application Zaupa et al., 2016 [413] Viral inhibitor Treatment of hepatitis C virus-related diseases using hydroxychloroquine or a combination of hydroxychloroquine and an anti-viral delta inhibitor and direct autophagy inhibitor US 9861623B1 Potentiating the apoptotic activity of deltarasin, a PDE-delta inhibitor by 3-methyladenine, a direct autophagy inhibitor for treatment of RAS positive cases. hepcidin is a key regulator of the entry of iron into the circulation. SENDA is associated with a mutation in the WIPI4 gene. the disease is characterized by iron accumulation in the globus pallidus. a severe decline in WIPI4 expression has been reported in lymphoblastoid cell lines. the mutations that eliminated or reduced Atg16L1 expression indicated a relationship between Atg16L1 mutations and Crohn\u2019s disease. other autophagy-associated proteins, including IRGM-101, 102, and 103 and NOD2-104, 105, and 106 have also been linked to Crohn\u2019s disease in humans. Danon disease is a rare cardiomyopathic disease caused by LAMP-2 deficiency. it is characterized by the accumulation of glycogen and autophagic vacuoles in cardiac and skeletal muscles, cardiomyopathy, and intellectual dysfunction. the gene is alternatively spliced into three isoforms (LAMP-2A, -2B, and -2C) which have different functions in autophagy. XMEA is characterized by progressive muscle weakness, particularly in the proximal muscles of the legs, and muscle degeneration (atrophy) in adulthood. XMEA also affects membrane repair, interrupts sarcolemmal membrane homeostasis, and increases serum creatine phosphokinase (CPK) levels. dysphagia (difficulty in swallowing) may occur due to weakness in the neck muscles of patients with sIBM. myalgia (muscle pain) and difficulty in manipulating objects may occur due to weakness in the fingers. an overview of diseases caused by genetic defects in autophagy genes. autophagic vacuoles in liver, kidney, pancreas, and cardiac and skeletal muscles Weakening of skeletal muscles D\u2019souza et al., 2014 [446]; Rothaug et al., 2015 [435]; Ng et al., 2016 [436] 5 X-linked myopathy with excessive autophagy (XMEA) Skeletal myopathy VMA21 Elevated levels of CPK Weakness in autophagosomes block maturation into degradative autolysosomes Facial dysmorphism and cataracts Zhao et al., 2013 [448] 8 Lysosomal storage disorder Niemann-Pick type C (NPC) Neurodegeneration and liver dysfunction NPC1 or NPC2 Compromised autophagy with accumulation of autophagosomes as evidenced by elevated LC3-II levels and LC3 positive vesicles in the NPC1 mutant anti-TSHR autoantibodies Graves' disease, hyperthyroidism Yao et al., 2018 [454] 14 Paget disease of bone (PDB) Osteoclast size, number and activity increase causing bone cleavage, cytoplasmic inclusions with protein aggregates responsible for autophagy Atg2B. microRNAs regulate cardiac autophagy by suppressing expression of autophagy-related genes in a targeted manner. autophagy plays a beneficial role against infectious diseases by simultaneously degrading pathogens and activating the host immune system. autophagy provides an excellent intracellular defense system against bacterial pathogens. bacterial peptidoglycans are detected by nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) following internalization. the bacteria-sensing NOD proteins interact with Atg16L1 to initiate anti-bacterial autophagosome biogenesis in response to bacterial invasion. Bacillus amyloliquefaciens was found to stimulate autophagy by elevating the expression of Beclin 1 and Atg5-Atg12-Atg16 complex. HLH-30/TFEB-mediated autophagy and autophagy pathways can regulate the tolerance of C. elegans to Bacillus thuringiensis infection by protecting against its pore-forming toxins. the murine macrophage cell line, RAW264.7, has been used to study Bacillus amyloliquefaciens SC06-induced autophagy and its anti-bacterial response against Escherichia coli. B. amyloliquefaciens stimulated autophagy by increasing the expression of Beclin 1 and the Atg5-Atg12-Atg16 complex, but not activating the AKT/mTOR signaling pathway. phagocytophilum replicates inside a double-lipid bilayer membrane associated with LC3 (Atg8), Beclin 1, and Atg6 but lacking lysosomal markers. another bacterium, Yersinia pseudotuberculosis, replicates intracellularly inside specific compartments called Yersinia-containing vacuoles (YCVs), which contain autophagy markers. autophagy targets invading intracellular bacterial pathogens for degradation. autophagy is differentially regulated in tuberculoid and lepromatous leprosy. autophagy controls Mycobacterium leprae, while in lepromatous cells, blocking of Bcl-2-mediated autophagy promotes bacterial persistence. studies of viral peptides have suggested a complex interaction between vacuoles and MHC class I presentation pathways in autophagosomes. autophagy is a major component of Drosophila immunity against vesicular stomatitis virus (VSV) as it can deliver viral antigens to TLRs for presentation. autophagy is often hijacked by viral pathogens and can be modulated to their own benefit. autophagy plays an important role in viral replication and pathogenesis [246], with coronaviruses [247], coxsackievirus B3 [248], poliovirus [249], hepatitis C virus [142,250,251,252], and deNV [143] all known to stimulate and require autophagy for accelerated replication. rapamycin, chloroquine, or small interfering RNAs target genes critical for autophagosome formation (Atg5 and Beclin 1) affects virus production. HIV induces the early stages of autophagy but inhibits the later stages which would suppress the production of new virions. nonstructural proteins (nsp6) induce the formation of omegasomes and autophagosomes from the ER via an omegasome intermediate. autophagy has been shown to induce the replication of infectious spleen and kidney necrosis virus (ISKNV) in the Chinese Perch Brain (CPB) cell line, suggesting complex interactions between ISKNV and host cells during viral pathogenesis. autophagy genes involved in regulation and execution of autophagy. some viruses encode the neurovirulence protein, ICP34.5. autophagy inhibition has been reported as a new molecular mechanism by which HSV-1 escapes innate immunity. autophagy evokes antiviral adaptive immunity via the endogenous presentation of viral antigens through the MHC class II pathway. autophagy plays a beneficial role against infectious diseases by simultaneously degrading pathogens and activating the host immune system. autophagy provides an excellent intracellular defense system against bacterial pathogens. the bacteria-sensing NOD proteins interact with Atg16L1 to initiate anti-bacterial autophagosome biogenesis in response to bacterial invasion. intracellular bacterial sensing either by NLRs or sequestosome-1-like receptors recruits autophagy proteins including unc-51-like kinase. autophagy and autophagy pathways regulate the tolerance of C. elegans to Bacillus thuringiensis infection by protecting against its pore-forming toxins. autophagy may activate innate immunity against mycobacteria via pattern recognition receptors. B. amyloliquefaciens stimulated autophagy by increasing the expression of Beclin 1 and the Atg5-Atg12-Atg16 complex. but not activating the AKT/mTOR signaling pathway. many bacteria have evolved mechanisms to overcome autophagy. yersinia pseudotuberculosis replicates intracellularly inside specific compartments called Yersinia-containing vacuoles (YCVs), which contain autophagy markers. yersinia pseudotuberculosis replicates intracellularly inside specific compartments called Yersinia-containing vacuoles (YCVs) autophagy targets invading intracellular bacterial pathogens for degradation. autophagy is differentially regulated in tuberculoid and lepromatous leprosy. autophagy controls Mycobacterium leprae, while in lepromatous cells, blocking of Bcl-2-mediated autophagy promotes bacterial persistence. autophagy is a major component of Drosophila immunity against vesicular stomatitis virus (VSV) [239] as it can deliver viral antigens to TLRs for presentation. pattern recognition receptors (PRRs) at the plasma membrane (i.e., Toll-7) stimulate an autophagy-dependent innate immune response mediated by PI3K-Akt-signaling. autophagy plays an important role in viral replication and pathogenesis [246], with coronaviruses [247], coxsackievirus B3 [248], poliovirus [249], hepatitis C virus [142,250,251,252], and deNV [143] all known to stimulate and require autophagy for accelerated replication. autophagy-deficient cells are more susceptible to apoptosis upon influenza infection [253,254], human immunodeficiency virus (HIV) uses multiple methods to regulate autophagy and enhance its replication. the HIV-1 accessory protein, Nef, inhibits autophagy by interacting with Beclin 1 [262], while the HIV protein Vpr can trigger autophagy in transfected THP-1 macrophages. rapamycin induces replication of infectious spleen and kidney necrosis virus (ISKNV) in the CPB cell line. inhibiting the autophagosomal pathway using 3-methyladenine or small-interfering RNAs decreased viral replication. disrupting autophagy using knockdown approach in hepatitis C virus stimulated interferon signaling pathway and induced apoptosis. autophagy genes involved in regulation and execution of autophagy. some viruses encode the neurovirulence protein, ICP34.5. autophagy inhibition has been reported as a new molecular mechanism by which HSV-1 escapes innate immunity. autophagy was thought to be involved in tumor suppression by stimulating gene expression, inhibiting proinflammatory mediators, inhibiting inflammation or inflammatory products, and stimulating signaling pathways. autophagy causes necrosis and chronic inflammation by inhibiting the release of pro-inflammatory HMGB1 which is involved in tumorigenesis [288] UVRAG protein suppresses tumorigenicity and proliferation of colonic cancer cells. mTOR is implicated in cancer and its substrates include eukaryotic initiation factor 4E (eIF4E)-binding proteins (4E-BPs) and the ribosomal S6 kinases (S6Ks) 1 and 2, which promote cell cycle progression. mTOR is inhibited by rapamycin [300] and molecules such as phosphatase and tensin homolog (PTEN) and tuberous sclerosis (TSC) can induce autophagy. novel anti-cancer molecule HA15, which targets HSPA5/BIP, was shown to induce ER stress and increase the unfolded protein response, resulting in cancer cell death via autophagy. autophagy signature protein BNIP3 has been shown in colorectal and gastric epithelial carcinomas. PPAR was shown to protect colon cancer cells against apoptosis induced by the interaction between butyrate and docosahexaenoic acid (DHA) in a cell type-dependent manner. autophagy is the only method by which neurons degrade and excrete expired organelles. autophagy is responsible for clearing abnormal intracytoplasmic contents from old neurons. mutations in Atg5 confined to neural tissues can cause impaired growth. autophagy can modulate notch degradation, stem cell development, and neurogenesis. autophagy is vital for neuronal homeostasis [326], and its deregulation is highly associated with numerous neurodegenerative effects. autophagy deficiency resulted in neuronal loss in the cerebral and cerebellar cortices in a mouse model. autophagy is involved in the clearance of -synuclein (-synuclein) by polo-like kinase 2 via autophagy. the PINK1 and Parkin genes regulate mitophagy. mutations in these genes can cause defects in mitophagy. regulating autophagy in the CNS could be a potential therapeutic approach against HIV-associated neurocognitive disorders. autophagy plays important roles in both innate and adaptive immunity [347], modulates cellular and humoral immune responses. autophagy regulates the functional responses of immune cells, such as phagocytosis, antigen presentation, cytokine production, control of inflammasome activation, tolerance. autophagy regulates the transcription of genes involved in cell proliferation, survival, differentiation, and development. activation of the inhibitor of NF-B kinase complex is essential for autophagy induction. interplay between Cytokine secretion and Autophagy IL-1 secretion is enhanced in Atg5-deficient macrophages. autophagy defects have been observed in T cells, B cells, and macrophages. increased lysosomal pH may be an important lysosomal malfunction involved in autoimmunity. autophagy can manage immunity-related and inflammatory diseases [82,345,347,364] by regulating cytokine and antibody production against immunogenic insults to prevent autoimmune diseases. autophagy plays important roles in both innate and adaptive immunity [347], modulates cellular and humoral immune responses [348,349,350], and plays an essential role in the renewal, differentiation, and homeostasis of immune cells [351]. in one study, the B cells of Atg5-deficient mice had defective antibody responses. autophagy can determine humoral immune responses. members of the NF-B family regulate the transcription of genes involved in cell proliferation, survival, differentiation, and development. autophagy adaptor p62/SQSTM1 modulates NF-B activation in B-cell lymphoma/leukemia. interplay between Cytokine secretion and Autophagy IL-1 secretion is enhanced in Atg5-deficient macrophages. anti-inflammatory cytokine inhibits autophagy by activating mTOR complex 1. autophagy could indicate the type of LN when formulating a treatment regimen. autophagy defects have been observed in T cells, B cells, and macrophages. autophagy has clinical potential in cancer immunotherapy 365. autophagy and adenoviral combinations are proving beneficial in adenoviral-based oncolytic virotherapy. autophagy levels vary in normal and stressed hearts. iron homeostasis involves a form of macroautophagy known as ferritinophagy. ferritin, an iron storage protein, is degraded in the lysosome. degradation of these contents provides essential resources that either promote cell survival or lead to cell death. autophagy inhibitor NCOA4 knockdown prevents the localization of ferritin in the lysosomes and increases the levels of iron-responsive element\u2013binding protein 2 (IRP2). ferritin is degraded to release the stored iron to maintain iron homeostasis. lysosomal enzymes cathepsin B (CTSB) and hexosaminidase subunit (HexB) impair normal lysosomal functioning. lysosomal enzymes cathepsin B (CTSB) and hexosaminidase subunit (HexB) impair normal lysosomal functioning and is carried out by denitrosylation enzymes, particularly S-nitroso autophagy by salicylamide derivates- anti-viral activity against - Cytopathic bovine viral diarrhea virus (cp-BVDV) flavivirus Needs et al., 2016 [243] Inhibition of Sindbis virus replication by overexpression of Beclin 1 Liang et al., 1998 [176] Enhanced autophagy by 1,25-dihydroxycholecalciferol reduces HIV replication. IFN- /RBV-based antiviral therapy-HCV Dash et al., 2016 [274] Inhibition of type-I IFN-independent signaling resulting in antibody-dependent enhancement (ADE) of Dengue virus. autophagy may be privileged by autophagy via an increase in ATP; Atg12-Atg5 complex is significantly upregulated. ER stress by DENV infection helps in autophagy and replication, both in vitro and in vivo. non-structural protein of virus affects mitochondrial membrane in Crimean-Congo Hemorrhagic fever causing apoptosis. replication of Brucella requires ULK1, Beclin 1, and Atg14L Starr et al., 2012 [227] Secreted phospholipases C (PLCs; PlcA and PlcB) and a surface protein (ActA) help Listeria monocytogenes multiplication Mitchell et al., 2018 [50] Shigella gatekeeper protein MxiC regulate type III secretion. pogostone stimulate autophagy and apoptosis through PI3K/Akt/mTOR axis and have anti-colorectal tumor activities. autophagy alleviates stressed condition \u2013 in hypoxic conditions, metabolic stress, shortage of energy, damaged mitochondria and other organelles. neurons Hara et al., 2006 [319] Atg5 mutation confined to neural tissue leads to impaired growth, progressive motor and behavioral deficits, prominent neurodegeneration and axonal swelling Absence of Atg59 and Atg710- leads to neuronal degeneration. autophagy dysregulation in cortical microvessels affects cortical vascular development. nuclear receptor co-activator 4 is responsible for directing ferritin to autophagosome. iron-responsive element-binding protein 2 (IRP2) prevent cell death by exogenous reactive oxygen species Berndt, 2014 [386] Ferritinophagy Iron storage protein called ferritin is degraded in the lysosome. 8 Compositions comprise a siRNA directed against an Atg gene to inhibit its expression Gorski SM, Qadir MA 13.12.11 Granted Gorski and Qadir 2011 [402] Dimeric quinacrine derivatives as autophagy inhibitors for cancer therapy WO 2016168721 Chloroquine compounds and derivatives mediated inhibition of lysosome Amaravadi RK, Winkler J. 20.10.16 Application Amaravadi and Winkler, 2016 autophagy enhancing compounds, peptides and peptidomimetic compounds for use in the treatment of neuronal diseases WO 2012076555 Pharmaceutical compositions enhancing autophagy in acute focal brain lesions D\u2019amelio M, Molinari M, Viscomi MT, Cecconi F 14.06.12 Application Jung and Lee, 2010 [408] Methods for reducing neurodegeneration EP 2717695 Inhibiting the expression of mTOR. autophagy enhancement and uses thereof US 9351946 Small molecules enhance autophagy and lysosome biogenesis by activating the gene TFEB Li M, Song J, Zeng Y, Liu L 31.05.16. autophagy modulator directly or indirectly acting on a complex involved in autophagy such as ULKl/2-Atgl3- FIP200 complex, Atg9 complex, STING complex, class III PI3K complex, ubiquitin-like conjug ducing peptide derived from beclin-1 (residues 269-283) has antiviral role against west Nile Virus, chikungunya virus, HIV and Ebola viru Levine BC, Sanae Shoji-Kawata S, Lichtarge O, Wilkins AD 14.02.17 Grant Levine et al., 2017 [416] Combination treatment of RAS-positive diseases with PDE-delta inhibitor and direct auto erythroferrone and erfe polypeptides can be regulated by herein polypeptides called erythroferrone and erfe polypeptides Ganz T, Nemeth E, Kautz L 08.05.14 Application Ganz et al., 2014 [421] 3.10. SENDA is a recently discovered type of neurodegeneration associated with iron accumulation in the brain. atg16L1 mutations have been found to be linked with Crohn\u2019s disease. mutations that eliminated or reduced Atg16L1 expression indicated a relationship between Atg16L1 mutations and Crohn\u2019s disease. other autophagy-associated proteins have also been linked to Crohn\u2019s disease. knockout of spastizin gene reduced autophagy and caused autophagosome accumulation by impairing lysosomal fusion. there are currently no treatments available to reverse nerve degeneration in HSP. there are currently no treatments available to reverse nerve degeneration. X-Linked Myopathy with Excessive Autophagy (XMEA) is a rare X-linked recessive skeletal myopathy caused by a single-nucleotide substitution (c. 164-7T > G) in VMA21. impaired hydrolase activity can block the final step of autophagy or induce autophagy by inhibiting mTOR. autophagosome formation is increased due to reduced cathepsin D and B activity during autophagosome maturation. allelic variants of the HLA-DR3 locus, other genetic factors, and the HLA genotype are also thought to play major roles in the progression and severity of the disease. autophagy and lysosomal function Vps15 knockouts exhibit muscle pathology similar to the XMEA. progressive quadriceps femoris and deep finger flexors weakness and atrophy Mastaglia. opathy, psychomotor retardation, and immunodeficiency with cleft lip and palate Recessive mutations in EPG5 deficiency blocks the maturation of autophagosomes into degradative autolysosomes. Deficiency blocks the maturation of autophagosomes into degradative autolysosomes resulting in accumulation of non-degradative autolysosomes. autophagic vesicle formation, immune cell development and function, mitochondrial ROS, antimicrobial immunity atg5 Disturbance in autophagic vesicle formation, immune cell development and function, mitochondrial ROS, antimicrobial immunity atg5 Disturbance in autophagic vesicle formation, immune cell development and function, mitochondrial ROS, antimicrobial immunity, e.g., HIV, bacteria Ye et al., 2018 [453] SENDA is a recently discovered type of neurodegeneration associated with iron accumulation in the brain. it begins with early-onset spastic paraplegia and mental retardation during childhood. the disease is characterized by iron accumulation in the globus pallidus. a severe decline in WIPI4 expression has been reported in lymphoblastoid cell lines. the loss of WIPI4 function is expressed in a mosaic pattern in females. atg16L1 mutations have been found to be linked with Crohn\u2019s disease. knockout of spastizin gene reduced autophagy and caused autophagosome accumulation by impairing lysosomal fusion. there are currently no treatments available to reverse nerve degeneration in HSP. there are currently no treatments available to reverse nerve degeneration. X-Linked Myopathy with Excessive Autophagy (XMEA) XMEA is a rare X-linked recessive skeletal myopathy caused by a single-nucleotide substitution (c. 164-7T > G) in VMA21. impaired hydrolase activity can block the final step of autophagy or induce autophagy by inhibiting mTOR. two major lysosomal proteases, cathepsins D and B, exhibit decreased activation in sIBM muscle fibers [441] while LC3-II is increased, indicating that autophagosome formation is increased due to reduced cathepsin D and B activity during autophagosome maturation. bowel disease Atg16L1 Inhibited LC3 conjugations to phosphatidylethanolamine (PE) Abdominal pain, diarrhea, vomiting, and weight loss Fujita et al., 2009 [430] 3 Hereditary spastic paraparesis (HSP) Increased muscle spasticity A recessive mutation in TECPR2 Autophagosome accumulation due to impaired fusion. epg5 deficiency blocks maturation of autophagosomes into degradative autolysosomes resulting in accumulation of non-degradative autolysosomes. neurodegeneration and liver dysfunction NPC1 or NPC2 Compromised autophagy with accumulation of autophagosomes. myelodysplastic syndromes / acute myeloid leukemia (AML) Accumulation of damaged mitochondria Atg7 Increased levels of ROS Bone marrow cells arecharacterized by mitochondrial abnormalities and increased cell death. Watson et al., 2011 [452] 12 Autoimmune/Autoinflammatory diseases Immune dysfunction Atg5 Disturbance in autophagic vesicle formation, immune cell development and function, mitochondrial ROS, antimicrobial immunity [ rhea, dehydration, indigestion, decreased appetite, stomach-ache and bloating, poor growth, and weight loss Comincini et al., 2017 [456] 16 Huntington disease Neurodegenerative disorder, CAG trinucleotide repeat in the 5\u2032 coding region of the IT15 gene of 4th chromosome IT15. -Type H (+)-ATPase Inhibitors 3-methyladenine (3-MA), a class-III PI3K inhibitor, is commonly used to inhibit autophagy. bafilomycin A1 is a vacuolar H+-ATPase inhibitor, which functions at concentrations as low as 1 nM to inhibit both the early and late stages of autophagy by activating the mTOR pathway. ated autophagy was found to be inhibited by cycloheximide [467]. cycloheximide is used to prevent the autophagy-lysosome pathway. hydroxychloroquine, NH4Cl, and neutral red are chemicals that can rapidly neutralize the acidic environment of the lysosome. cathepsins are aspartic, cysteine, and serine proteases that are transported to lysosomes via mannose-6-phosphate receptors. cathepsins are aspartic, cysteine, and serine proteases that are transported to lysosomes via mannose-6-phosphate receptors. cathepsins D and E are inhibited by pepstatin A. the leucine-rich repeat kinase 2 gene (LRRK2) is associated with Crohn\u2019s disease, Parkinson\u2019s disease, and leprosy. the atg16L1 300 T > A polymorphism has been demonstrated to disrupt unconventional TMEM59.110-mediated autophagy in mice. three SMERs were identified from 50,729 compounds that can induce autophagy. SMERs 10, 18, and 28 can reduce pathogenesis associated with polyglutamine aggregation and A53T -synuclein. trehalose is a natural disaccharide known to stimulate autophagy via AMPK. lentztrehaloses A, B, and C were synthesized and found to be as effective as trehalose. lithium has already been approved by the FDA for patients with bipolar disorder. long-term oral lithium administration enhanced autophagy in a mouse model. the antiepileptic compound, carbamazepine, has been found to protect cells against M. tuberculosis infection, likely by inducing autophagy [512]. bacterial pore-forming toxins can induce autophagy and thus reduce the risk of hepatocellular carcinoma (HCC) in diabetic patients. the use of thioxanthone-based autophagy inhibitor is currently at the patent filing phase. the herbal product Onjisaponin B, from Radix Polygalae (Polygala tenuifolia) is known to enhance autophagy. it prevents, treats, or delays the onset of neurodegenerative diseases. a gliosis experimental model revealed that EGCG reduced reactive gliosis and retinal damage. EGCG should be explored as a treatment of diabetic retinopathy. -ATPase Inhibitors 3-methyladenine (3-MA), a class-III PI3K inhibitor, is commonly used to inhibit autophagy. bafilomycin A1 is a vacuolar H+-ATPase inhibitor, which functions at concentrations as low as 1 nM to inhibit both the early and late stages of autophagy by activating the mTOR pathway. chloroquine, hydroxychloroquine, NH4Cl, and neutral red are chemicals that can rapidly neutralize the acidic environment of the lysosome. chloroquine-mediated lysosomal dysfunction is thought to have increased anti-cancer functions when combined with nutrient deprivation. cathepsins are aspartic, cysteine, and serine proteases that are transported to lysosomes via mannose-6-phosphate receptors. cathepsins are aspartic, cysteine, and serine proteases that are transported to lysosomes via mannose-6-phosphate receptors. cathepsins D and E are inhibited by pepstatin A. the leucine-rich repeat kinase 2 gene (LRRK2) is associated with Crohn\u2019s disease, Parkinson\u2019s disease, and leprosy. the atg16L1 300 T > A polymorphism has been demonstrated to disrupt unconventional TMEM59.110-mediated autophagy in mice. inhibitors as bafilomycin A1 and in the presence of autophagosomes cause autophagic bodies to accumulate in the central vacuole and cytoplasm of tobacco BY-2 cells. cadmium chloride- or hyperosmotic sucrose-stimulated autophagy was found to be inhibited by cycloheximide [467], which likely inhibits autophagy at the segregation step. hydroxychloroquine, NH4C chloroquine Lys05 effectively accumulates within the lysosome to concurrently deacidify and inhibit autophagy. protease inhibitor leupeptin inhibits cysteine, serine, and threonine peptidases to block protein degradation. cathepsins are aspartic, cysteine, and serine proteases that are transported to lysosomes via mannose-6-phosphate receptors. miR-885-3p targets ULK2 to regulate autophagy. miRNA-30a/b, miRNA-376b, miR-216a, miR-519a, and miR-17-5p inhibit Beclin 1 expression to suppress vesicle nucleation. rapamycin has been shown to increase autophagy, decrease cyclin D1 expression, and attenuate aggressive IgA nephropathy progression in a rat model. the small molecule AUTEN-99 activates autophagy in cell cultures and animal models. trehalose is a natural disaccharide known to stimulate autophagy via AMPK [494] trehalose treatment has been shown to increase the conversion of LC3-I to LC3-II via an mTOR-independent pathway. sucrose and raffinose are also known to induce autophagy. bioavailability of trehalose in the body for autophagy induction is low due to the hydrolytic enzyme, trehalase, which is expressed in the intestine and kidney. increased concentrations of LC3-II and Beclin 1 can reduce intracellular inositol-1,4,5 trisphosphate levels. spermidine also inhibits EP300 and the major autophagy proteins, Atg5, Atg7, Atg12, and LC3 to repress autophagy. a patent for a thioxanthone-based autophagy inhibitor is currently at the patent filing phase. the herbal product Onjisaponin B, from Radix Polygalae (Polygala tenuifolia) is known to enhance autophagy. it prevents, treats, or delays the onset of neurodegenerative diseases. epigallocatechin gallate (EGCG) was found to promote autophagosome formation and increase lysosome acidification in M\u00fcller cells, thus increasing autophagy. rapamycin inhibits the mTOR and RAD001 and AP23573 are rapamycin derivatives having comparatively higher safely with minimal dose toxicities. the rapamycin ester CCI-779/Temsilorimus, also known as sirolimus, is a natural mTOR inhibitor [485] that stimulates autophagy both in vitro and in vivo. the rapamycin ester CCI-779/Temsilorimus, which is also an mTOR inhibitor, prevents the development of intracellular tau protein inclusions. trehalose Trehalose is a natural disaccharide known to stimulate autophagy via AMPK. trehalose is a natural disaccharide known to stimulate autophagy via AMPK. trehalose can also reduce the levels of aggregate-prone proteins. ol monophosphatase (IMPase) reduces inositol and inositol-1,4,5-triphosphate (IP3) levels. long-term oral lithium administration enhanced autophagy in a mouse model. a bisphosphonate inhibitor of IMPase exhibits a similar function to lithium. the antiepileptic compound, carbamazepine, has been found to protect cells against M. tuberculosis infection, likely by inducing autophagy [512]. bacterial pore-forming toxins can induce autophagy and reduce the risk of hepatocellular carcinoma (HCC) in diabetic patients [515]. polygala tenuifolia is a traditional Chinese herb known to enhance autophagy. it prevents, treats, or delays the onset of neurodegenerative diseases. a patent for this product has been granted to law et al. chloroquine/hydroxychloroquine, NH4Cl, and leupeptin rapidly neutralize the acidic environment of the lysosome. leupeptin inhibits cysteine, serine and threonine peptidases, and hence blocking protein degradation at the last step of autophagy. autophagy is linked with other cellular mechanisms such as apoptosis, necrosis, autosis, and necroptosis. autophagy can be selective, neutralizing specific substances, or non-selective, degrading different materials irrespective of their nature. autophagy encounters infectious and non-infectious diseases, either mediating protection or aggravating the disease. autophagy stimulators could be controlled with drugs such as cycloheximide, lysosome alkalizers and acidic protease inhibitors. upregulating autophagy could therapeutically benefit a range of diseases caused by reduced neuronal apoptosis. autophagy could prevent various bacterial and viral diseases, inflammatory and autoimmune conditions, and also increase lifespan. autophagy modulating drugs are imprecise and nonspecific. autophagy upregulation appears to be beneficial for removing misfolded and aggregated proteins, intracellular pathogens, damaged mitochondria, and other organelles."}